Pathogenesis of hypertrophic cardiomyopathy associated with hepatitis C virus.
与丙型肝炎病毒相关的肥厚型心肌病的发病机制。
基本信息
- 批准号:10470164
- 负责人:
- 金额:$ 6.53万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The importance of hepatitis C virus (HCV) infection has recently been noted in patients with hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM).In a collaborative research project of the Committees for the Study of Idiopathic Cardiomyopathy, HCV antibody was found in 74 of 697 patients (10.6%) with HCM and in 42 of 663 patients (6.3%) with DCM; this prevalence was significantly higher than measured in volunteer blood donors in Japan (2.4%).A collaborative multicenter study, chaired by Dr.B.Maisch, was performed to test the reproducibility of detection of detection of viral genomes such as enteroviruses, adenovirus, cytomegalovirus and HCV in formalin fixed tissues. Autopsy and biopsy materials were analyzed blindly. Hepatitis C virus genomes were found in the hearts of 2 out of 11 patients (18%) with dilated cardiomyopathy and myocarditis from Italy, and 4 out of 11 patients (36%) from the United States. We attempted to detect HCV genomes in paraffin sections of autopsied hearts. Among 106 hearts examined, β-actin gene was amplified in 61 hearts (52.6%). Among these, HCV RNA was detected in 13 hearts (21.3%), and negative strands in 4 hearts (6.6%). HCV RNA was found in 6 hearts (26.0%) with HCM, 3 heart (11.5%) with DCM, and 4 hearts (33.3%) with myocarditis. These HCV RNA positive samples were obtained between 1979 and 1990, indicating that HCV RNA can be amplified from paraffin-embedded hearts preserved for many years. We also analyzed autopsied hearts with DCM in a collaborative research with the University of Utah, and found HCV RNA in 8 of 23 hearts (35%) with positive actin genes. The sequences of HCV genomes recovered from these hearts were closely homologous to the standard strain of HCV.
最近,丙型肝炎病毒(HCV)感染在肥厚型心肌病(HCM)或扩张型心肌病(DCM)患者中的重要性已被注意到。在特发性心肌病研究委员会的一项合作研究项目中,697例HCM患者中有74例(10.6%)发现HCV抗体,663例DCM患者中有42例(6.3%)发现HCV抗体;这一流行率明显高于日本志愿献血者(2.4%)。一项由b博士主持的多中心合作研究。Maisch,对福尔马林固定组织中肠病毒、腺病毒、巨细胞病毒和丙型肝炎病毒等病毒基因组检测的重复性进行检验。对尸检和活检资料进行盲目分析。在意大利11例扩张型心肌病和心肌炎患者中2例(18%)的心脏中发现了丙型肝炎病毒基因组,在美国11例患者中4例(36%)的心脏中发现了丙型肝炎病毒基因组。我们试图在解剖心脏的石蜡切片中检测HCV基因组。在106颗心脏中,61颗(52.6%)的β-肌动蛋白基因扩增。其中,13例(21.3%)心脏检出HCV RNA, 4例(6.6%)心脏检出阴性链。HCV RNA出现在HCM患者6例(26.0%),DCM患者3例(11.5%),心肌炎患者4例(33.3%)。这些HCV RNA阳性样本是在1979年至1990年间获得的,表明保存多年的石蜡包埋心脏可以扩增出HCV RNA。在与犹他大学的合作研究中,我们还分析了患有DCM的尸检心脏,发现23颗心脏中有8颗(35%)的HCV RNA呈肌动蛋白基因阳性。从这些心脏中恢复的HCV基因组序列与HCV标准株密切同源。
项目成果
期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsumori A, et al.: "Circulating hepatocyte growth factor as an early marker of arterial thrombus formation." Jpn Circ J. 62. 311-313 (1998)
Matsumori A 等人:“循环肝细胞生长因子作为动脉血栓形成的早期标志物。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsumori A,et al.: "Coronary reperfusion and cytokines." Edited by Abiko Y, Karmazyn M Springer-Verlag, Tokyo, 157-177(20) (1998)
Matsumori A 等人:“冠状动脉再灌注和细胞因子”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukukawa Y, et al.: "Anti-monocyte chemoattractant protein-I/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries"Circ Res. 84. 306-314 (1999)
Fukukawa Y 等人:“抗单核细胞趋化蛋白-I/单核细胞趋化和激活因子抗体抑制受损大鼠颈动脉中的新内膜增生”Circ Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hara M, Matsumori A, Ono K, Kido H, Hwang MW, Miyamoto T, Iwasaki A, Okada M, Nakatani K, Sasayama S.: "Mast cells apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vivo."Circulation. 100. 1443-1449 (1999)
Hara M、Matsumori A、Ono K、Kido H、Hwang MW、Miyamoto T、Iwasaki A、Okada M、Nakatani K、Sasayama S.:“体内心肌细胞的肥大细胞凋亡和其他心肌内细胞的增殖。”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Furukawa Y.et al.: "Cytokine gene expression during the development of graft coronary artery disease in mice"Jpn Circ J. 63. 775-782 (1999)
Furukawa Y.等人:“小鼠移植冠状动脉疾病发生过程中的细胞因子基因表达”Jpn Circ J. 63. 775-782 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUMORI Akira其他文献
MATSUMORI Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUMORI Akira', 18)}}的其他基金
International study on the prevalence of viral infection in myopcardial diseases
心肌疾病病毒感染流行率的国际研究
- 批准号:
18406029 - 财政年份:2006
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of mast cells, stem cell factor and c-kit in heart failure
肥大细胞、干细胞因子和c-kit在心力衰竭中的作用
- 批准号:
16390223 - 财政年份:2004
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cytokine gene therapy of cardiovascular diseases by in vivo electroporation
体内电穿孔细胞因子基因治疗心血管疾病
- 批准号:
13557063 - 财政年份:2001
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of an animal model of cardiomyopathy by transfering hepatitis C virus genome.
通过转移丙型肝炎病毒基因组开发心肌病动物模型。
- 批准号:
11557050 - 财政年份:1999
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Mechanism of the pathogenesis of myocarditis and cardiomyopathy due to hepatitis C virus
丙型肝炎病毒引起的心肌炎和心肌病的发病机制
- 批准号:
08457207 - 财政年份:1997
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the pathogenesis of cardiomyopathy by quantitation of messenger RNA.
通过信使RNA定量研究心肌病的发病机制。
- 批准号:
04454263 - 财政年份:1992
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Development of diagnostic method to detect enterovirus by polymerase chain reaction
开发聚合酶链反应检测肠道病毒的诊断方法
- 批准号:
03557042 - 财政年份:1991
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
A study on autoimmune mechanism in the pathogenesis of myocarditis of cardiomyopathy analysis by anti-heart monoclonal antibody
抗心脏单克隆抗体分析心肌病心肌炎发病机制中的自身免疫机制
- 批准号:
02454255 - 财政年份:1990
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
MicroRNA-195在糖尿病性心肌病发生中的作用及其机理的探讨
- 批准号:81170204
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions
使用混合数字孪生解决方案对肥厚型心肌病患者进行分层、管理和指导
- 批准号:
10109598 - 财政年份:2024
- 资助金额:
$ 6.53万 - 项目类别:
EU-Funded
The role of energy sensor signaling in mitochondrial cardiomyopathy
能量传感器信号在线粒体心肌病中的作用
- 批准号:
10995416 - 财政年份:2024
- 资助金额:
$ 6.53万 - 项目类别:
DETERMINANTS OF OUTCOME TO DISEASE-MODIFYING THERAPY FOR TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY
转甲状腺素蛋白淀粉样变性心肌病疾病缓解治疗结果的决定因素
- 批准号:
495435 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
- 批准号:
495567 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Miscellaneous Programs
A study on the identification of target factors for elucidation of the pathogenesis of hypertrophic cardiomyopathy and development of novel treatments
阐明肥厚型心肌病发病机制和开发新疗法的靶标因素的研究
- 批准号:
22KJ1699 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Effect of High Salt Diet on Proximal Tubular Sodium Reabsorption, Metabolic Stress, and Injury
高盐饮食对近端肾小管钠重吸收、代谢应激和损伤的影响
- 批准号:
10908784 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
In vivo precision genome editing to correct genetic disease
体内精准基因组编辑以纠正遗传疾病
- 批准号:
10771419 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Role of endothelial cell senescence in age-related cardiomyopathy
内皮细胞衰老在年龄相关性心肌病中的作用
- 批准号:
10726050 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:
Endothelial Smad3 as a Novel Target to Avert Chemotherapy Induced Cardiomyopathy
内皮 Smad3 作为避免化疗引起的心肌病的新靶点
- 批准号:
10730342 - 财政年份:2023
- 资助金额:
$ 6.53万 - 项目类别:














{{item.name}}会员




